BRPI0921230A2 - agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo. - Google Patents
agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo.Info
- Publication number
- BRPI0921230A2 BRPI0921230A2 BRPI0921230A BRPI0921230A BRPI0921230A2 BR PI0921230 A2 BRPI0921230 A2 BR PI0921230A2 BR PI0921230 A BRPI0921230 A BR PI0921230A BR PI0921230 A BRPI0921230 A BR PI0921230A BR PI0921230 A2 BRPI0921230 A2 BR PI0921230A2
- Authority
- BR
- Brazil
- Prior art keywords
- neuropeptide
- receptor agonists
- agonists
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2271—Neuropeptide Y
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11144208P | 2008-11-05 | 2008-11-05 | |
PCT/EP2009/064034 WO2010052144A2 (en) | 2008-11-05 | 2009-10-26 | Neuropeptide-2-receptor (y-2r) agonists and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0921230A2 true BRPI0921230A2 (pt) | 2018-10-30 |
Family
ID=42077641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0921230A BRPI0921230A2 (pt) | 2008-11-05 | 2009-10-26 | agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100179093A1 (pt) |
EP (1) | EP2352511A2 (pt) |
JP (1) | JP2012507487A (pt) |
KR (1) | KR20110097807A (pt) |
CN (1) | CN102202681A (pt) |
AU (1) | AU2009312892A1 (pt) |
BR (1) | BRPI0921230A2 (pt) |
CA (1) | CA2741921A1 (pt) |
IL (1) | IL212364A0 (pt) |
MX (1) | MX2011004427A (pt) |
WO (1) | WO2010052144A2 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9260500B2 (en) | 2009-07-02 | 2016-02-16 | Takeda Pharmaceutical Company Limited | Peptide and use thereof |
WO2011045232A2 (en) * | 2009-10-13 | 2011-04-21 | F. Hoffmann-La Roche Ag | Neuropeptide-2 receptor (y-2r) agonists |
PT2651398T (pt) | 2010-12-16 | 2018-03-09 | Novo Nordisk As | Composições sólidas compreendendo um agonista de glp-1 e um sal de ácido n-(8-(2-hidroxibenzoil)amino) caprílico |
HUE062740T2 (hu) | 2012-03-22 | 2023-12-28 | Novo Nordisk As | GLP-1 peptidek készítményei és elõállításuk |
GB201315335D0 (en) * | 2013-08-29 | 2013-10-09 | Of Singapore | Amino diacids containing peptide modifiers |
CN105764919B (zh) | 2013-11-15 | 2021-04-27 | 诺和诺德股份有限公司 | 在位置35具有β-高精氨酸置换的hPYY(1-36) |
US10246497B2 (en) | 2013-11-15 | 2019-04-02 | Novo Nordisk A/S | Selective PYY compounds and uses thereof |
US10588980B2 (en) | 2014-06-23 | 2020-03-17 | Novartis Ag | Fatty acids and their use in conjugation to biomolecules |
MY187047A (en) | 2015-06-12 | 2021-08-27 | Novo Nordisk As | Selective pyy compounds and uses thereof |
JOP20190097A1 (ar) * | 2016-10-27 | 2019-04-28 | Janssen Pharmaceutica Nv | الجلوبولينات المناعية واستخداماتها |
CN111683676B (zh) | 2018-02-02 | 2024-06-18 | 诺和诺德股份有限公司 | 包含glp-1激动剂、n-(8-(2-羟基苯甲酰基)氨基)辛酸的盐和润滑剂的固体组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5080891A (en) * | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
US6013633A (en) * | 1997-08-07 | 2000-01-11 | University Of Cincinnati | Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
US7410949B2 (en) * | 2005-01-18 | 2008-08-12 | Hoffmann-La Roche Inc. | Neuropeptide-2 receptor (Y-2R) agonists and uses thereof |
WO2006096565A2 (en) * | 2005-03-04 | 2006-09-14 | Curedm Inc. | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
AU2006324076A1 (en) * | 2005-12-07 | 2007-06-14 | F. Hoffmann-La Roche Ag | Neuropeptide-2 receptor-agonists |
-
2009
- 2009-10-26 WO PCT/EP2009/064034 patent/WO2010052144A2/en active Application Filing
- 2009-10-26 AU AU2009312892A patent/AU2009312892A1/en not_active Abandoned
- 2009-10-26 CA CA2741921A patent/CA2741921A1/en not_active Abandoned
- 2009-10-26 EP EP09740144A patent/EP2352511A2/en not_active Withdrawn
- 2009-10-26 KR KR1020117012795A patent/KR20110097807A/ko not_active Application Discontinuation
- 2009-10-26 BR BRPI0921230A patent/BRPI0921230A2/pt not_active IP Right Cessation
- 2009-10-26 JP JP2011533695A patent/JP2012507487A/ja active Pending
- 2009-10-26 CN CN2009801440699A patent/CN102202681A/zh active Pending
- 2009-10-26 MX MX2011004427A patent/MX2011004427A/es not_active Application Discontinuation
- 2009-11-02 US US12/610,417 patent/US20100179093A1/en not_active Abandoned
-
2011
- 2011-04-14 IL IL212364A patent/IL212364A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN102202681A (zh) | 2011-09-28 |
EP2352511A2 (en) | 2011-08-10 |
KR20110097807A (ko) | 2011-08-31 |
WO2010052144A2 (en) | 2010-05-14 |
AU2009312892A1 (en) | 2010-05-14 |
JP2012507487A (ja) | 2012-03-29 |
IL212364A0 (en) | 2011-06-30 |
CA2741921A1 (en) | 2010-05-14 |
MX2011004427A (es) | 2011-05-31 |
WO2010052144A3 (en) | 2010-07-08 |
US20100179093A1 (en) | 2010-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0921230A2 (pt) | agonistas de receptor de neuropeptídeos-2 (y-2r) e usos dos mesmo. | |
BRPI0922483A2 (pt) | agonista de receptor gpr120 e usos dos mesmos | |
BRPI0914891A2 (pt) | agonistas de aril gpr119 e usos dos mesmos | |
BRPI0918868A2 (pt) | moduladores do receptor de nmda e usos dos mesmos | |
BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
BRPI0912198A2 (pt) | anticorpos anti-fn14 e usos dos mesmos | |
BRPI0920927A2 (pt) | derivados de azaquinolinona e usos dos mesmos | |
BRPI1013943A2 (pt) | Composto cetais e usos dos mesmos. | |
BRPI0918122A2 (pt) | molécula de diaboy, diaboy, e mólecula dart | |
BRPI0917358A2 (pt) | formulação farmacêutica de liberação controlada e método. | |
BRPI0920209A2 (pt) | conjugados de agonistas de glp-1 e usos dos mesmos | |
FR2934188B1 (fr) | Dispositif de serrage | |
BRPI0920962A2 (pt) | variantes de polipeptídeos receptores de activina iib e usos dos mesmos | |
BRPI0915142A2 (pt) | polipeptídeos, ácido nucleico e usos dos mesmos | |
BRPI0920406A2 (pt) | dispositivos de terminação e métodos relacionados. | |
BRPI0915433A2 (pt) | método, e, dispositivo. | |
BRPI0818477A2 (pt) | Dc-sign, icam-3 e lsectin porcinos e usos dos mesmos | |
BRPI0918502A2 (pt) | aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos | |
BRPI0912615A2 (pt) | agonistas de receptor y2 e/ou y4 de longa ação | |
BRPI0822337A2 (pt) | Folatos, composições e usos dos mesmos | |
BRPI0920953A2 (pt) | dispositivo de manutenção, e uso do mesmo. | |
BRPI0807911A2 (pt) | Agonistas de alfa2c adrenorreceptor | |
BRPI0913188A2 (pt) | moduladores de receptores 5-ht3, métodos de fabricação, e uso dos mesmos | |
BRPI0921997A2 (pt) | dispositivo para medição do componente de sangue. | |
FR2935737B1 (fr) | Dispositif de cogeneration amelioree |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2497 DE 13-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |